Citation: Jr. Kunta et al., Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics, COMPAR MED, 51(4), 2001, pp. 349-356
Citation: Gm. Grass et Pj. Sinko, Effect of diverse datasets on the predictive capability of ADME models in drug discovery, DRUG DISC T, 6(12), 2001, pp. S54-S61
Authors:
Ramanathan, S
Pooyan, S
Stein, S
Prasad, PD
Wang, JH
Leibowitz, MJ
Ganapathy, V
Sinko, PJ
Citation: S. Ramanathan et al., Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide, PHARM RES, 18(7), 2001, pp. 950-956
Citation: Mj. Hoffmann et al., Pharmacokinetic studies in Tg.AC and FVB mice administered [C-14]benzene either by oral gavage or intradermal injection, TOX APPL PH, 174(2), 2001, pp. 139-145
Authors:
Sutyak, JP
Lee, YH
Perry, BA
Stern, W
Makhey, V
Sinko, PJ
Citation: Jp. Sutyak et al., Improved longevity and functionality of a canine model providing portal vein and multi-site intestinal access, COMPAR MED, 50(2), 2000, pp. 167-174
Authors:
Lee, YH
Perry, BA
Sutyak, JP
Stern, W
Sinko, PJ
Citation: Yh. Lee et al., Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs, PHARM RES, 17(3), 2000, pp. 284-290
Authors:
Puri, N
Weyand, EH
Abdel-Rahman, SM
Sinko, PJ
Citation: N. Puri et al., An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems, VACCINE, 18(23), 2000, pp. 2600-2612
Citation: N. Puri et al., Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres I. In vitro characterization, J CONTR REL, 69(1), 2000, pp. 53-67
Citation: N. Puri et Pj. Sinko, Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres II. In vitro investigation, J CONTR REL, 69(1), 2000, pp. 69-80
Citation: Pv. Balimane et Pj. Sinko, Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells, BIOPHARM DR, 21(5), 2000, pp. 165-174
Authors:
Lee, YH
Perry, BA
Labruno, S
Lee, HS
Stern, W
Falzone, LM
Sinko, PJ
Citation: Yh. Lee et al., Impact of regional intestinal pH modulation on absorption of peptide drugs: Oral absorption studies of salmon calcitonin in beagle dogs, PHARM RES, 16(8), 1999, pp. 1233-1239
Authors:
Sinko, PJ
Lee, YH
Makhey, V
Leesman, GD
Sutyak, JP
Yu, HS
Perry, B
Smith, CL
Hu, PD
Wagner, EJ
Falzone, LM
McWhorter, LT
Gilligan, JP
Stern, W
Citation: Pj. Sinko et al., Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In vitro permeability and in vivo oral absorption of salmon calcitonin (sCT), PHARM RES, 16(4), 1999, pp. 527-533
Citation: Pv. Balimane et Pj. Sinko, Involvement of multiple transporters in the oral absorption of nucleoside analogues, ADV DRUG DE, 39(1-3), 1999, pp. 183-209
Citation: Da. Norris et al., Determining the absolute surface hydrophobicity of microparticulates usingthin layer wicking, J CONTR REL, 59(2), 1999, pp. 173-185
Citation: Al. Guo et al., Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line, J PHARM EXP, 289(1), 1999, pp. 448-454
Citation: Da. Norris et al., The effect of physical barriers and properties on the oral absorption of particulates, ADV DRUG DE, 34(2-3), 1998, pp. 135-154